Exec Summary: The future of mental health chatbots is likely to be one of cautious optimism. While they hold the potential to improve...

Exec Summary: Based on recent press reports, Apple is showing strong signs of entering the smart ring market, competing with Samsung and...

Exec Summary: Quantum entanglement communication is a fascinating area of research that utilises the strange phenomenon of quantum...

Exec Summary: Tourist investors defined as 'generalist' and 'crossover' investors have slowed down their funding of Healthcare Technology...

Exec Summary: The JP Morgan Healthcare Conference 2024 was a whirlwind of news, trends, and insights for the healthcare industry. Here...

Exec Summary: Artificial emotional intelligence (AEI), also known as affective computing or emotion AI, is a field of artificial...

HealthInvestor gathered perspectives from industry experts such as Paul Tomasic, Houlihan Lokey, Molly Gilmartin, AlbionVC, Michelle...

Exec Summary: Google Care Studio is a cloud-based healthcare data management platform that enables healthcare providers to create and...

Palantir Technologies is a software company that specializes in big data analytics. The company has a number of products that are designed to help organisations make better decisions based on data. Palantir's products are used by a variety of industries, including healthcare. Palantir's plans for healthcare include using its products to help organisations improve patient care, reduce costs, and improve efficiency.

Exec Summary: The bridges and tunnels in healthcare technology are the infrastructure and systems that enable the efficient and reliable...

Exec Summary There is a growing body of evidence that suggests that large language models (LLMs) can be effective in a variety of...

Exec Summary Patient engagement and patient portals are expected to play an increasingly important role in healthcare by 2030. As...

Exec Summary: In vitro diagnostics (IVD) is an emerging HealthTech sub sector that is expected to see significant growth in 2024 and...

Exec Summary: The HealthTech IPO market is expected to recover in the summer of 2024 with a number of factors now starting to build and...

Private equity firms have traditionally focused on investing in large, high-growth healthcare technology companies. However, there is a growing opportunity for private equity firms to tap into the midtier of the healthtech landscape. These midtier companies have demonstrated a proof of concept, have won flagship customers, and are consistently profitable. However, they are unlikely to reach billion-dollar valuations. This makes them attractive targets for private equity fi